Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03297762 · ClinicalTrials.gov registry record · NA
Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03297762: Clinical Trial NA study, sponsored by Stanford University.
NCT03297762 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03297762, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).
Interventions
- BEHAVIORAL gamification
- BEHAVIORAL Use of Dexcom G5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03297762
The ClinicalTrials.gov registry entry for NCT03297762 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which gamification is the first listed.
NCT03297762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03297762 about?
NCT03297762 is a clinical study titled "Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes". To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).
What is the current status of trial NCT03297762?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-05-07. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03297762?
The interventions under investigation include: gamification (BEHAVIORAL), Use of Dexcom G5 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03297762?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.